Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metallocene antimalarials: the continuing quest.

Margaret A L Blackie1, Kelly Chibale

  • 1Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.

Metal-Based Drugs
|February 16, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychedelics and Entactogens.

Journal of medicinal chemistry·2026
Same author

The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite <i>Plasmodium falciparum</i> via Polypharmacological Inhibition of <i>Pf</i>Ark1 and Hemozoin Formation.

ACS chemical biology·2026
Same author

Effect of Stereochemistry on the Antiplasmodial Activity and Metabolomic Profile of Novel Tadalafil Analogues.

ACS medicinal chemistry letters·2026
Same author

Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib.

Clinical pharmacology and therapeutics·2026
Same author

Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study.

ACS omega·2026
Same author

Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors.

European journal of medicinal chemistry·2026
Same journal

Mutagenic Tests Confirm That New Acetylacetonate Pt(II) Complexes Induce Apoptosis in Cancer Cells Interacting with Nongenomic Biological Targets.

Metal-based drugs·2011
Same journal

Regulation of Cisplatin cytotoxicity by cu influx transporters.

Metal-based drugs·2011
Same journal

Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Metal-based drugs·2010
Same journal

Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.

Metal-based drugs·2010
Same journal

Cytotoxic properties of titanocenyl amides on breast cancer cell line mcf-7.

Metal-based drugs·2010
Same journal

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion.

Metal-based drugs·2009
See all related articles

Researchers explored novel antimalarial compounds by modifying ferroquine, a successful metallocene-based drug. New derivatives, including ruthenoquine and heterobimetallic compounds, were synthesized and tested against Plasmodium falciparum.

Area of Science:

  • Medicinal Chemistry
  • Organic Chemistry
  • Parasitology

Background:

  • Metallocene-containing compounds, particularly ferroquine, have shown promise as antimalarial agents.
  • Developing new antimalarial drugs is crucial due to increasing drug resistance in Plasmodium falciparum.
  • Introducing structural diversity into known antimalarial scaffolds can lead to improved efficacy or novel mechanisms of action.

Purpose of the Study:

  • To synthesize and evaluate novel ferroquine derivatives and related metallocene-based compounds as potential antimalarial drugs.
  • To explore the impact of replacing the ferrocenyl group with ruthenocene.
  • To create and assess heterobimetallic derivatives incorporating gold and rhodium.

Main Methods:

  • Synthesis of ferroquine derivatives with modifications in the side chain.

Related Experiment Videos

  • Preparation of ruthenoquine and its analogues by replacing ferrocene with ruthenocene.
  • Reaction of ferroquine and analogues with gold and rhodium complexes to form heterobimetallic compounds.
  • In vitro antiplasmodial activity testing against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum strains.

    • Main Results:

    • A series of ferroquine derivatives were synthesized, introducing diversity into the side chain.
    • Ruthenoquine and its analogues were prepared, showing modest activity.
    • Several heterobimetallic derivatives containing gold and rhodium were successfully synthesized.
    • Preliminary structure-activity relationships were established based on in vitro antiplasmodial activity.

    Conclusions:

    • The study successfully generated diverse metallocene-based antimalarial candidates.
    • Ruthenocene-containing analogues and heterobimetallic complexes represent new avenues for antimalarial drug discovery.
    • Further investigation into these novel compounds may lead to effective treatments against malaria.